Rentschler Biopharma and ATUM Announce Leap-In Transposase® Licensing Agreement for Development of Robust Manufacturing Processes for Complex Therapeutic Proteins

LAUPHEIM, Germany & MILFORD, Mass. & NEWARK, Calif.--(BUSINESS WIRE)-- #Biotech--ATUM’s technology will strategically enhance Rentschler Biopharma’s cell line development services and capabilities.

Click to view original post